HIF1A and non-small cell lung carcinoma: Studies have shown that in non-small cell lung cancer (NSCLC), CHCHD2 and HIF-1α co-localise in both the cytoplasm and the nucleus, with CHCHD2 overexpression significantly promoting that of HIF-1α (Yin et al., 2020).